PMC9382239_01
CD4+ lymphocytes counts during the treatment of an HIV-positive patient with difficult-to-treat RA with using adalimumab. Normal CD4+ lymphocyte count: 1488-4483U/muL.
fimmu-13-942642-g001.jpg
PMC9382239_01_fimmu-13-942642-g001.jpg
f1
HAART was initiated. HIV-1 RNA viral replication was controlled, and the CD4+ lymphocyte count continued to increase (Figure 1).